COMMUNIQUÉS West-GlobeNewswire

UroGen Pharma to Ring the Nasdaq Stock Market Opening Bell

24/04/2018 - 14:00

RA’ANANA, Israel and NEW YORK, April 24, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN ), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with [...]

Intercept Pharmaceuticals Appoints Nancy Miller-Rich to Its Board of Directors

24/04/2018 - 14:00

NEW YORK, April 24, 2018 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT ), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]

Radius Health to Announce First Quarter 2018 Financial Results, Host Conference Call and Live Webcast on May 10, 2018

24/04/2018 - 14:00

WALTHAM, Mass., April 24, 2018 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq: RDUS ) announced today that it will release its first quarter financial results on Thursday, May 10, 2018. The Company will host a conference [...]

PolarityTE Announces Appointment of McKesson’s Willie Bogan to Board of Directors

24/04/2018 - 14:00

SALT LAKE CITY, April 24, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq: COOL ), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, [...]

Shire plc : Statement re revised proposal

24/04/2018 - 13:47

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT [...]

Avadel Pharmaceuticals to Report First Quarter 2018 Results

24/04/2018 - 13:30

DUBLIN, Ireland, April 24, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL ), today announced it will report its first quarter 2018 financial results on Wednesday, May 2, 2018, before the market open. [...]

Cytokinetics Announces Presentation of Data From Phase 2 Clinical Study of Reldesemtiv in Patients With Spinal Muscular Atrophy at the 2018 Annual Cure SMA Conference

24/04/2018 - 13:30

SOUTH SAN FRANCISCO, Calif., April 24, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK ) today announced that data from the Phase 2 clinical study of reldesemtiv in patients with spinal muscular [...]

Orion Group Interim Report January-March 2018

24/04/2018 - 11:01

ORION CORPORATION INTERIM REPORT JANUARY-MARCH 2018 24 APRIL 2018 at 12:00 EEST Orion Group Interim Report January-March 2018 Orion's net sales for continuing operations in January-March 2018 totalled EUR 247 million ( [...]

ViaDerma, Inc. Enters into a $250,000 Initial Sales Agreement with Vage Nigeria Ltd.

24/04/2018 - 11:00

LOS ANGELES, April 24, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), is pleased to announce it has entered into a $250,000 initial sales agreement with Vage Nigeria Ltd. (“Vage”), a brand support [...]

Galapagos reports initiation of FALCON clinical trial in cystic fibrosis

24/04/2018 - 08:46

Our first triple combination investigational therapy for CF patients combination of '2451+'2222+'2737 multiple centers in Europe topline results expected Q3 2018 Mechelen, Belgium; 24 April 2018; 08.45 AM CET - [...]

Shire plc : Rule 2.9 Announcement

24/04/2018 - 08:01

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 24 April 2018 [...]

Lysogene Signs Partnership Agreement with Dr. Hervé Moine, Researcher at the IGBMC(1) and the SATT(2) Conectus Alsace, in the Fragile X Syndrome

24/04/2018 - 08:00

Development of a gene therapy product for the treatment of patients with Fragile X syndrome Implementation of the project through a unique partnership First results anticipated in 2019 CAMBRIDGE, Mass. and PARIS, April [...]

Interim Report January-March 2018

24/04/2018 - 08:00

Summary Q1 IN BRIEF The study design for PledOx ® Phase III program has been approved by the UK Medicines Agency MHRA and accepted by the US FDA and the Central Ethics Committee of the United States PledOx ® shows [...]

Notice of annual shareholders’ meeting in Saniona AB

24/04/2018 - 08:00

PRESS RELEASE April 24, 2018 The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. The shareholders in Saniona [...]

Notification from Oasmia Pharmaceutical AB

24/04/2018 - 08:00

Uppsala, Sweden, April 24, 2018 – Oasmia Pharmaceutical AB hereby issues a notification regarding the issuance of the agenda for EMA’s CHMP meeting April 23 – 26. Instead of the announced oral explanation, Oasmia will [...]

Sanofi Head of Global R&D Elias Zerhouni to retire; Company names John Reed to take over on July 1

24/04/2018 - 07:31

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi Head of Global R&D Elias Zerhouni to retire; Company names John Reed to take over on July 1 Paris - 24 th April 2018 -- Elias Zerhouni, M.D., Head of [...]

Départ à la retraite du Président Monde de la R&D de Sanofi, Elias Zerhouni ; L'entreprise nomme John Reed pour lui succéder à compter du 1er juillet

24/04/2018 - 07:31

Communiqué de presse Source : Sanofi (EURONEXT : SAN) (NYSE : SNY) Départ à la retraite du Président Monde de la R&D de Sanofi, Elias Zerhouni ; L'entreprise nomme John Reed pour lui succéder à compter du 1 er [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

24/04/2018 - 07:01

REGULATED INFORMATION GHENT, Belgium, 24 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

Targovax ASA: Invitation to first quarter 2018 results presentation Thursday 3 May

24/04/2018 - 07:01

Oslo, Norway, 24 April 2018 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, will announce its first quarter 2018 results on Thursday, 3 May [...]